BRAIN Biotech AG
Develops enzymes and microorganisms for the food, chemical, and life sciences sectors.
BNN | F
Overview
Corporate Details
- ISIN(s):
- DE0005203947 (+1 more)
- LEI:
- 391200JKPVHLD6JLZ107
- Country:
- Germany
- Address:
- Darmstädter Straße 34-36, 64673 Zwingenberg
- Website:
- https://www.brain-biotech.com/
Description
BRAIN Biotech AG is an industrial biotechnology company specializing in the discovery, development, and production of specialty enzymes, high-performance microorganisms, and bioactive compounds. The company provides tailor-made biosolutions and contract research and development (R&D) services to partners in the food, chemical, and life sciences sectors. Core competencies include enzyme technology, microbial strain development, and bioprocess development. By leveraging an advanced technology portfolio, which includes proprietary platforms for enzyme discovery and genome editing, the company enables its partners to create more sustainable and efficient industrial products and processes, contributing to the bioeconomy.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2022-10-13 14:52 |
EQS-DD: BRAIN Biotech AG english
|
English | HTML • 8.0 KB | ||
| 2022-10-13 14:46 |
EQS-DD: BRAIN Biotech AG english
|
English | HTML • 8.0 KB | ||
| 2022-09-27 07:30 |
Change in the Executive Management Board of BRAIN Biotech AG, genome editing ac…
|
English | HTML • 13.1 KB | ||
| 2022-09-26 17:20 |
BRAIN Biotech AG sells subsidiary L.A. Schmitt to a URI group company
|
English | HTML • 12.5 KB | ||
| 2022-09-14 09:26 | German | HTML • 14.3 KB | |||
| 2022-08-29 07:30 |
BRAIN Biotech AG: On Track to Reach Financial Year 2021/22 Targets, 9M Reporting
|
English | HTML • 21.8 KB | ||
| 2022-08-29 00:00 |
Q3 statement / Q3 financial report 2021/2022
|
German | PDF • 251.9 KB | ||
| 2022-06-20 08:00 |
BRAIN Biotech publishes first ESG and Sustainability Report
|
English | HTML • 12.7 KB | ||
| 2022-06-03 00:00 |
Half-yearly financial report 2021/2022
|
German | PDF • 1.9 MB | ||
| 2022-05-30 09:00 |
BRAIN Biotech AG: Prof. Dr. Bernhard Hauer leaves Supervisory Board of BRAIN Bi…
|
English | HTML • 9.7 KB | ||
| 2022-05-30 07:30 |
BRAIN Biotech AG: Ongoing Dynamic Sales Development and Rising Profitability, 6…
|
English | HTML • 19.6 KB | ||
| 2022-05-30 00:00 |
Halbjahresfinanzbericht
|
German | HTML • 109.5 KB | ||
| 2022-05-23 14:18 | English | HTML • 4.0 KB | |||
| 2022-05-23 00:00 |
Hinweis auf Halbjahresfinanzbericht vom 01.10.2021 bis zum 31.03.2022
|
German | HTML • 5.8 KB | ||
| 2022-04-07 16:42 |
DGAP-DD: BRAIN Biotech AG english
|
English | HTML • 7.6 KB |
Automate Your Workflow. Get a real-time feed of all BRAIN Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BRAIN Biotech AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BRAIN Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-03 | Schneiders, Michael | Board | Buy | None | 25,000.00 EUR |
| 2025-01-16 | Moelker, Adriaan | Board | Buy | None | 35,795.96 EUR |
Peer Companies
